Dr. Allan Levey, MD, Ph.D., of Emory University, has received a grant from the National Institutes of Health (NIH) for $7.2M for Alzheimer’s disease research.  The purpose of this study is to discover proteins ‘beyond the usual suspects of beta-amyloid and tau’ that are altered by Alzheimer’s disease, in an effort to identify new targets for therapies.

Dr. Levey received the first CART Grant awarded in 1999.

Six university research centers will collaborate in this research.  Five of the participating research centers are CART Grant recipients: Emory University, UCLA, University of Washington, University of Pennsylvania and Johns Hopkins.  Rush University is also participating.

While beta-amyloid and tau are considered by most of the scientific community to be the culprits causing AD, the research to date involving these two proteins have yet to result in successful therapies.